Back to News
Market Impact: 0.3
Eli Lilly Breaks Ground On $6.5 Bln Houston Manufacturing Facility
Source: Nasdaq
Healthcare & BiotechCompany FundamentalsInfrastructure & Defense
Eli Lilly has begun construction of a $6.5 billion manufacturing facility in Houston, Texas. The plant will produce active pharmaceutical ingredients for Foundayo, other small-molecule medicines, and advanced therapeutics, expanding Lilly's pharmaceutical manufacturing capacity.
AllMind Terminal
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request TrialMarket Sentiment
Overall Sentiment
moderately positive
Sentiment Score
0.45
Ticker Sentiment
LLY0.65
More News
- Dozens of people sue GLP-1 drug companies over alleged vision loss
- Roche obesity drug shows 15.5% weight loss in diabetes trial
- South Korean solar stocks jump as curbs on Chinese sector expected to remain in place
- ‘I have a big decision to make’: Trump had a ‘good meeting’ with Iranian officials warning he may ‘annihilate the Islamic Republic’
- Zelenskyy says Ukraine ready for energy truce with Russia after Trump talks
- South Korea’s Lee, Trump welcome progress in US strategic investment projects